It is most important to treat as well as prevent any diseases.
EYEREUM has been acknowledged for continually succeeding in the treatment of keratoconus and has been selected as Korea KERARING Center of Excellence by MEDIPHACOS Inc., an international medical company for keratoconus treatment ‘KERA-RING.’
Also, the Chief Director of EYEREUM, Dr. David Kang(David Sung Yong Kang) has been appointed as the only ambassador in Asia for the Avedro Medical Advisory Board, MAB, which consists of 15 world renowned medical specialists. He is working hand in hand with world leading specialists to establish a safety standard for the treatment and prevention of keratoconus. And EYEREUM is taking the initiative to acquire advanced medical technologies and provide them to patients in Korea.
Corneal Collagen Cross-linking: building a stronger cornea.
LASIK, LASEK, Xtra® using the innovative KXL system enhances the bindings of corneal collagen molecules and adds strength to the cornea. It eliminates any side-effects and provides safety for patients with extreme myopia.
The MAB (Medical Advosiroy Board) members chosen by Avedro Inc. U.S.A. are comprised of ophthalmologic specialists from around the world. And each member is contributing to the development of new medical technologies with corneal cross-linking.
- 01 After undergoing the standard LASIK surgery, riboflavin (Vitamin B2) VibeX eye-drops are applied to the cornea and left to soak for 90 seconds.
- 02 The cornea is illuminated with 45mW/㎠ ultra violet light for 90 seconds using the KXL system.
- 03 Biomechanical strength is added to the cornea, strengthening the collagen binding.
Already more than 100,000 surgeries performed over the World.
100,000 Cross-linking surgeries have already been performed in the world. It is a procedure that has been used to treat keratoconus for the past 10 years. As patients who have undergone the cross-linking procedure after their LASIK or LASEK surgery have shown a stable vision as well as no signs of myopia regression or keratoconus.
|-||KXL System||Standard Cross-linking Procedure|
|UVA exposure method||High Fluence Pulsed Energy||Continuous Energy|
|Vitamin B2 saturation time||90 sec.||about 30~40 minutes|
|UVA exposure time||90 sec.||about 40 minutes|
|Features||Can bind more collagens in a short
amount of time.
|91% chance of corneal opacity|
SCI(Science Citation Index)논문 등재
아이리움안과의 연구 결과가 등재된 ‘SCI’ 란, 미국 톰슨사이언티팩社가 만든 과학기술분야 학술잡지에 게재된 논문의 색인을 수록한 데이터 베이스를 말합니다. SCI는 등록 여부만으로도 세계적인 권위를 인정받을 정도로 영향력있는 학술지 평가의 기준입니다.
아이리움안과의 의료진은 현재까지 SCI 논문을 약 55편(2020년 5월 기준) 게재 하였습니다. 또한, 안과학계 최고의 권위를 자랑하는 국제학술지 안과시과학연구(IOVS : Investigative Ophthalmology and Visual Science) 저널의 ‘리뷰어 (Reviewer)’로 위촉, 현재 활동 중입니다. (‘IOVS 리뷰어’란 IOVS의 등재를 원하는 수많은 학술자료들의 타당성을 검토하는 역할을 수행하는 심사위원 입니다.)